Neal D. Shore, MD, FACS
U.S. Chief Medical Officer (CMO) of Surgery and Oncology
Dr. Neal Shore joined GenesisCare in 2011 as National Urology Research Director and serves as director of the Carolina Urologic Research Center. As an award-winning urologist, he has conducted more than 350 clinical trials focusing mainly on genitourinary oncology. Dr. Shore has served on numerous executive, urology, government, and administrative boards throughout his career, including the Society of Urologic Oncology and the Bladder Cancer Advocacy Network. His clinical expertise has positioned him as an internationally recognized expert and researcher in systematic therapies and treatments for patients with advanced urologic cancers for the prostate, kidney, and bladder.
In his new role, Dr. Shore will use his over 30 years of urologic oncology expertise to support both evidence-based pathways and research opportunities for our patients, our healthcare teams, and communities throughout the U.S.
Dr. Shore completed his bachelor’s in Public Policy Sciences and his doctor of medicine at Duke University. At the New York Hospital – Cornell Medical Center, he completed residencies in urology and general surgery, including a 6-month surgical rotation at Memorial Sloan Kettering Cancer Center.
Dr. Shore is based in Myrtle Beach, South Carolina.
